Nifuroxazide CAS:965-52-6
Prevention and treatment of intestinal or urinary system diseases caused by Escherichia coli, Salmonella, Pasteurella (including riemannia), aerogenic bacteria, proteus, necrotizing bacteria and Staphylococcus. It can effectively prevent diarrhea and promote animal feeding.
Qinmu Nifuroxazide DESCRIPTION
Item | Specifications |
Appearance | Bright yellow crystalline powder |
Solubility | Practically insoluble in water, slightly soluble in alcohol and practically insoluble in methylene chloride |
Loss on drying | 0.5% Max |
Heavy metals(Pb) | 0.002% Max |
Sulphated ash | 0.1% Max |
Identification by IR | The IR Spectrum confirms with the reference spectrum |
Related substance | Impurity A ≤0.005%Impurity B ≤0.3%Impurity C ≤0.3%Impurity D ≤0.3%Impurity E ≤0.3%Signal unspecified impurities ≤0.1%Total impurities other than E ≤0.5%Total ≤0.5%Disregard limit ≤0.05% |
UV.Absorption | The specific absorption at about 367nm is between 940-1000 |
Residual solvents | Methanol ≤0.3%Alcohol ≤0.5% |
Assay (On dried) | 98.5~101.5% |
Package: 25KG/drum or according to clients' requirements.
Storage: in a dry and ventilated warehouse; keep away from sunshine and moisture.
Pharmaceuticals supplier: JINAN QINMU FINE CHEMICAL CO.LTD
more @ www.qinmuchem.com
Copyright：@2020-2021
Comments Please sign in or sign up to post.
0
0 of 500 characters used